Idriss H T, Hannun Y A, Boulpaep E, Basavappa S
School of Biomedical Sciences, Centre for Biomolecular Sciences, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, Scotland, UK.
J Physiol. 2000 May 1;524 Pt 3(Pt 3):629-36. doi: 10.1111/j.1469-7793.2000.00629.x.
P-glycoprotein (Pgp) is a transmembrane transporter causing efflux of a number of chemically unrelated drugs and is responsible for resistance to a variety of anticancer drugs during chemotherapy. Pgp overexpression in cells is also associated with volume-activated chloride channel activity; Pgp is thought to regulate such activity. Reversible phosphorylation is a possible mechanism for regulating the transport and chloride channel regulation functions of Pgp. Protein kinase C (PKC) is a good candidate for inducing such phosphorylation. Hierarchical multiple phosphorylation (e.g. of different serines and with different PKC isoforms) may shuttle the protein between its different states of activity (transport or channel regulation). Cell volume changes may trigger phosphorylation of Pgp at sites causing inhibition of transport. The possible regulation of chloride channels by Pgp and the potential involvement of reversible phosphorylation in such regulation is reviewed.
P-糖蛋白(Pgp)是一种跨膜转运蛋白,可导致多种化学结构不相关的药物外排,并且在化疗期间对多种抗癌药物产生耐药性。细胞中Pgp的过表达还与容积激活的氯离子通道活性相关;人们认为Pgp可调节这种活性。可逆磷酸化是调节Pgp转运和氯离子通道调节功能的一种可能机制。蛋白激酶C(PKC)是诱导这种磷酸化的一个很好的候选者。分级多重磷酸化(例如不同丝氨酸位点以及不同PKC同工型的磷酸化)可能使该蛋白在其不同的活性状态(转运或通道调节)之间转换。细胞容积变化可能触发Pgp在导致转运抑制的位点发生磷酸化。本文综述了Pgp对氯离子通道可能的调节作用以及可逆磷酸化在这种调节中的潜在作用。